Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes. (Q45929111)
Jump to navigation
Jump to search
scientific article published on 26 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes. |
scientific article published on 26 September 2016 |
Statements
1 reference
Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes. (English)
1 reference
Michael J Haller
1 reference
Stephen E Gitelman
1 reference
Peter A Gottlieb
1 reference
Aaron W Michels
1 reference
Daniel J Perry
1 reference
Andrew R Schultz
1 reference
Maigan A Hulme
1 reference
Jonathan J Shuster
1 reference
Baiming Zou
1 reference
Clive H Wasserfall
1 reference
Amanda L Posgai
1 reference
Clayton E Mathews
1 reference
Todd M Brusko
1 reference
Mark A Atkinson
1 reference
Desmond A Schatz
1 reference
26 September 2016
1 reference
1 reference
65
1 reference
3765-3775
1 reference
12
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference